Preclinical studies have demonstrated bexotegrast may effectively inhibit TGF-β activation and reduce collagen deposition in lung fibroblast cultures and animal models of lung fibrosis [153]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.